Endeavor

How Accurate Is a Staging Laparoscopy in Guiding Treatment Eligibility?

A study spearheaded at Moffitt Cancer Center analyzes the accuracy of how eligibility for heated chemotherapy is decided

Do Gastric and Esophageal Cancer Patients Benefit From More Chemotherapy Before Surgery?

Moffitt study shows patients who receive more treatment before surgery may responded better

HEPZATO Kit Continues To Improve Uveal Melanoma Outcomes After FDA Approval

The treatment was approved by the FDA in 2023 following a phase 3 trial at Moffitt

Compassion in the Most Critical Moments

Jennifer Cox, MD, is Moffitt’s 2025 Physician of the Year

Study Finds Plant-Based Diets Linked to Lower Overall Cancer Risk, With Some Exceptions

The results suggest benefits from plant-forward diets while reminding researchers and clinicians that nutrition and cancer risk are shaped by many factors

Physician Urges Colorectal Cancer Screening After Own Diagnosis

Before becoming a patient at Moffitt, Alex Hayes worked at the cancer center as a radiology resident

Can GLP-1s Reduce Cancer Risk?

Research suggests that GLP-1 medications such as Ozempic and Wegovy may help protect against certain types of cancer

Immunotherapy Pioneer Steven Rosenberg Reflects on Past Breakthroughs and Future Promise

Legendary researcher connects immunotherapy’s origins to its future at Moffitt

Can a Personalized Treatment Stop Bladder Cancer From Coming Back?

The mRNA treatment targets and attacks cells carrying a patient’s unique mutations